Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
5-aminosalicylic acid poisoning |
Causative agent (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental 5-aminosalicylic acid poisoning (disorder) |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional 5-aminosalicylic acid poisoning (disorder) |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
5-aminosalicylic acid poisoning of undetermined intent |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
5-aminosalicylic acid adverse reaction (disorder) |
Causative agent (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine adverse reaction |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Olsalazine adverse reaction (disorder) |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulphasalazine adverse reaction |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to mesalazine |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalazine allergy |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to olsalazine |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfasalazine allergy |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
5-aminosalicylic acid overdose |
Causative agent (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental 5-aminosalicylic acid overdose |
Causative agent (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional 5-aminosalicylic acid overdose |
Causative agent (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
5-aminosalicylic acid overdose of undetermined intent |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 1g/100mL retention enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalazine 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalazine 500 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalazine 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalazine 1g/dose rectal foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalamine 2g/59mL enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalazine 1g/sachet m/r granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalazine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rectal mesalazine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalamine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mesalazine 66.7 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalamine 400mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalamine 500mg/suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalamine 250mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Balsalazide disodium |
Is a |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalazine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 500mg/sachet m/r granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental 5-aminosalicylic acid poisoning (disorder) |
Causative agent (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional 5-aminosalicylic acid poisoning (disorder) |
Causative agent (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to mesalazine |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalamine 375mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to mesalazine |
Causative agent (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to mesalazine |
Causative agent (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Mesalamine 400mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalamine 375mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalamine 250mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mesalazine 500mg/sachet gastro-resistant and prolonged-release oral granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant oral tablet |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 500 milligram/1 each prolonged-release oral tablet |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 500 milligram/1 each prolonged-release oral tablet |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 250 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 250 mg rectal suppository |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 500 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 500 mg rectal suppository |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only mesalazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug) |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 66.7 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 66.7 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalamine therapy |
Direct substance |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 2 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 2 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 4 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 4 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1.5 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1.5 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 3 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 3 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 500 milligram/1 sachet prolonged-release oral granules (clinical drug) |
Has precise active ingredient |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 500 milligram/1 sachet prolonged-release oral granules (clinical drug) |
Has basis of strength substance (attribute) |
False |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 500 mg gastro-resistant and prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 500 mg gastro-resistant and prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 1.5 g gastro-resistant and prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 1.5 g gastro-resistant and prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 3 g gastro-resistant and prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mesalazine 3 g gastro-resistant and prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 4 gram/1 sachet gastro-resistant and prolonged-release oral granules (clinical drug) |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 4 gram/1 sachet gastro-resistant and prolonged-release oral granules (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mesalazine 500 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Mesalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |